1,102
Views
42
CrossRef citations to date
0
Altmetric
Research Article

Development and characterization of ligand-appended liposomes for multiple drug therapy for pulmonary tuberculosis

, , &
Pages 52-59 | Received 17 May 2012, Accepted 10 Jun 2012, Published online: 14 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Pooneh Kia, Umme Ruman, Ariyati Retno Pratiwi & Mohd Zobir Hussein. (2023) Innovative Therapeutic Approaches Based on Nanotechnology for the Treatment and Management of Tuberculosis. International Journal of Nanomedicine 18, pages 1159-1191.
Read now
Priya Shrivastava, Laxmikant Gautam, Rajeev Sharma, Devyani Dube, Sonal Vyas & Suresh P. Vyas. (2021) Dual antitubercular drug loaded liposomes for macrophage targeting: development, characterisation, ex vivo and in vivo assessment. Journal of Microencapsulation 38:2, pages 108-123.
Read now
Flavio De Maio, Valentina Palmieri, Marco De Spirito, Giovanni Delogu & Massimiliano Papi. (2019) Carbon nanomaterials: a new way against tuberculosis. Expert Review of Medical Devices 16:10, pages 863-875.
Read now
Mrunal Jadhav, Tabassum Khan, Chintan Bhavsar, Munira Momin & Abdelwahab Omri. (2019) Novel therapeutic approaches for targeting TB and HIV reservoirs prevailing in lungs. Expert Opinion on Drug Delivery 16:7, pages 687-699.
Read now
Piyush Mehta, C. Bothiraja, Shivajirao Kadam & Atmaram Pawar. (2018) Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages S791-S806.
Read now
Najla M. Salkho, Vinod Paul, Pierre Kawak, Rute F. Vitor, Ana M. Martins, Mohammad Al Sayah & Ghaleb A. Husseini. (2018) Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 462-472.
Read now
Ankur Bhardwaj, Shuchi Mehta, Shailendra Yadav, Sudheer K. Singh, Anne Grobler, Amit Kumar Goyal & Abhinav Mehta. (2016) Pulmonary delivery of antitubercular drugs using spray-dried lipid–polymer hybrid nanoparticles. Artificial Cells, Nanomedicine, and Biotechnology 44:6, pages 1544-1555.
Read now
Wing-Hin Lee, Ching-Yee Loo, Daniela Traini & Paul M Young. (2015) Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages. Expert Opinion on Drug Delivery 12:6, pages 1009-1026.
Read now

Articles from other publishers (33)

Ayushi Nair, Alosh Greeny, Amritasree Nandan, Ranjay Kumar Sah, Anju Jose, Sathish Dyawanapelly, Vijayabhaskarreddy Junnuthula, Athira K. V.Prashant Sadanandan. (2023) Advanced drug delivery and therapeutic strategies for tuberculosis treatment. Journal of Nanobiotechnology 21:1.
Crossref
Mashudu T. Mphaphuli, Mduduzi N. Sithole, Pradeep Kumar, Pierre P.D. Kondiah, Mostafa Mabrouk & Yahya E. Choonara. (2023) Multi-purpose prototypes for extrapulmonary Mycobacterium tuberculosis targeting: A regenerative medicine perspective. Journal of Drug Delivery Science and Technology 89, pages 105039.
Crossref
Prakash Khadka, Jack Dummer, Philip C. Hill, Rajesh Katare & Shyamal C. Das. (2022) A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation. Drug Delivery and Translational Research 13:5, pages 1246-1271.
Crossref
Sumita Singh, Kunal Arora, Kamal Dua & Lubhan Singh. 2023. Natural Polymeric Materials based Drug Delivery Systems in Lung Diseases. Natural Polymeric Materials based Drug Delivery Systems in Lung Diseases 61 79 .
Nurfatihah Azlyna Ahmad Suhaimi, Suhana Ahmad, Siti Muhamad Nur Husna, Maria Elena Sarmiento, Armando Acosta, Mohd Nor Norazmi, Jamal Ibrahim, Rohimah Mohamud & Ramlah Kadir. (2022) Application of liposomes in the treatment of infectious diseases. Life Sciences 305, pages 120734.
Crossref
Nidhi Nainwal, Yuwanshi Sharma & Vikash Jakhmola. (2022) Dry powder inhalers of antitubercular drugs. Tuberculosis 135, pages 102228.
Crossref
Mani Sharma & Sakshi Kansal. 2022. Contemporary Issues in Global Medicine and Moving Toward International Healthcare Equity. Contemporary Issues in Global Medicine and Moving Toward International Healthcare Equity 317 347 .
Luis Ángel Ibarra-Sánchez, Ana Gámez-Méndez, Manuel Martínez-Ruiz, Erik Francisco Nájera-Martínez, Brando Alan Morales-Flores, Elda M. Melchor-Martínez, Juan Eduardo Sosa-Hernández, Roberto Parra-Saldívar & Hafiz M.N. Iqbal. (2022) Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis. Journal of Drug Delivery Science and Technology 70, pages 103219.
Crossref
Joandra Maísa da Silva Leite, Yuri Basilio Gomes Patriota, Mônica Felts de La Roca & José Lamartine Soares-Sobrinho. (2022) New Perspectives in Drug Delivery Systems for the Treatment of Tuberculosis. Current Medicinal Chemistry 29:11, pages 1936-1958.
Crossref
Maharshi Thalla & Subham Banerjee. 2022. Nanoengineering of Biomaterials. Nanoengineering of Biomaterials 371 410 .
Pooja Sanjay Khairnar, Ajit Singh & Rahul Shukla. 2022. Nanotechnology for Infectious Diseases. Nanotechnology for Infectious Diseases 387 417 .
Mangesh Pradeep Kulkarni, Poluri Sesha Sai Kiran & Rajesh Kumar. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases 471 492 .
Kristyna Krasulova & Peter Illes. (2021) Intestinal interplay of quorum sensing molecules and human receptors. Biochimie 189, pages 108-119.
Crossref
Lucila Garcia-Contreras, Vasu Sethuraman, Masha Kazantseva & Anthony Hickey. (2021) Efficacy of Combined Rifampicin Formulations Delivered by the Pulmonary Route to Treat Tuberculosis in the Guinea Pig Model. Pharmaceutics 13:8, pages 1309.
Crossref
Tarun Sahu, Yashwant Kumar Ratre, Sushma Chauhan, L.V.K.S. Bhaskar, Maya P. Nair & Henu Kumar Verma. (2021) Nanotechnology based drug delivery system: Current strategies and emerging therapeutic potential for medical science. Journal of Drug Delivery Science and Technology 63, pages 102487.
Crossref
Goutam Rath, Deepak Pradhan, Goutam Ghosh & Amit K. Goyal. (2021) Challenges and Opportunities of Nanotechnological based Approach for the Treatment of Tuberculosis. Current Pharmaceutical Design 27:17, pages 2026-2040.
Crossref
Priya Shrivastava, Laxmikant Gautam, Anamika Jain, Nikhar Vishwakarma, Sonal Vyas & Suresh P. Vyas. 2021. Handbook of Research on Nano-Strategies for Combatting Antimicrobial Resistance and Cancer. Handbook of Research on Nano-Strategies for Combatting Antimicrobial Resistance and Cancer 87 113 .
Annu, Ali Sartaj, Nidhi Aggarwal, Zufika Qamar, Heena Tabassum, Jasjeet K. Narang, Sanjula Baboota & Javed Ali. 2021. Nanocarriers for the Delivery of Combination Drugs. Nanocarriers for the Delivery of Combination Drugs 47 83 .
Prabakaran Selvakani, Sumathra Murugan & Mariappan Rajan. 2021. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy 31 58 .
SN Andreevskaya, TG Smirnova, EN Antonov, LN Chernousova, SE Bogorodsky, EE Larionova, VK Popov & A Ergeshov. (2020) New in vitro model to evaluate kinetics of antimycobacterial drug release from bioresorbable polymeric carriers. Bulletin of Russian State Medical University:2020(4), pages 10-15.
Crossref
Fereshteh Bayat, Reza Hosseinpour-Moghadam, Fatemeh Mehryab, Yousef Fatahi, Niayesh Shakeri, Rassoul Dinarvand, Timo L.M. Ten Hagen & Azadeh Haeri. (2020) Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation. Advances in Colloid and Interface Science 277, pages 102121.
Crossref
Amlan Chakraborty & Cordelia Selomulya. 2020. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems 303 321 .
Damián Eduardo Pérez-Martínez & Roberto Zenteno-Cuevas. 2020. Nanotechnology Based Approaches for Tuberculosis Treatment. Nanotechnology Based Approaches for Tuberculosis Treatment 37 52 .
Caleb F. Anderson, Maria E. Grimmett, Christopher J. Domalewski & Honggang Cui. (2019) Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases. WIREs Nanomedicine and Nanobiotechnology 12:1.
Crossref
Afzal Hussain, Sima Singh, Sabya Sachi Das, Keshireddy Anjireddy, Subramanian Karpagam & Faiyaz Shakeel. (2019) Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control. Current Drug Delivery 16:5, pages 400-429.
Crossref
Oluwatoyin A. Adeleke, Pei-Chin Tsai, Krizia M. Karry, Nkwe O. Monama & Bozena B. Michniak-Kohn. (2018) Isoniazid-loaded orodispersible strips: Methodical design, optimization and in vitro-in silico characterization. International Journal of Pharmaceutics 547:1-2, pages 347-359.
Crossref
Lalit Kumar, Shivani Verma, Bhuvaneshwar Vaidya & Neelesh K. Mehra. 2017. Nanostructures for Antimicrobial Therapy. Nanostructures for Antimicrobial Therapy 293 324 .
Burcu Devrim & Asuman Bozkır. 2017. Nanostructures for Antimicrobial Therapy. Nanostructures for Antimicrobial Therapy 169 202 .
Pio Maria Furneri, Giulio P. Petronio, Virginia Fuochi, Sarha Cupri & Rosario Pignatello. 2017. Nanostructures for Drug Delivery. Nanostructures for Drug Delivery 697 748 .
Amit K. Goyal, Tarun Garg, Sourav Bhandari & Goutam Rath. 2017. Nanostructures for Drug Delivery. Nanostructures for Drug Delivery 669 695 .
Thaigarajan Parumasivam, Rachel Yoon Kyung Chang, Sharif Abdelghany, Tian Tian Ye, Warwick John Britton & Hak-Kim Chan. (2016) Dry powder inhalable formulations for anti-tubercular therapy. Advanced Drug Delivery Reviews 102, pages 83-101.
Crossref
A.P. Ingle, S. Shende, R. Pandit, P. Paralikar, S. Tikar, K. Kon & M. Rai. 2016. The Microbiology of Respiratory System Infections. The Microbiology of Respiratory System Infections 223 235 .
Bhushan S. Pattni, Vladimir V. Chupin & Vladimir P. Torchilin. (2015) New Developments in Liposomal Drug Delivery. Chemical Reviews 115:19, pages 10938-10966.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.